252 related articles for article (PubMed ID: 10416757)
1. An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy.
Vorwerk CK; Gorla MS; Dreyer EB
Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S142-50. PubMed ID: 10416757
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma.
Neufeld AH
Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S129-35. PubMed ID: 10416755
[TBL] [Abstract][Full Text] [Related]
3. Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma.
Wamsley S; Gabelt BT; Dahl DB; Case GL; Sherwood RW; May CA; Hernandez MR; Kaufman PL
Arch Ophthalmol; 2005 Jan; 123(1):64-70. PubMed ID: 15642814
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection in relation to retinal ischemia and relevance to glaucoma.
Osborne NN; Ugarte M; Chao M; Chidlow G; Bae JH; Wood JP; Nash MS
Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S102-28. PubMed ID: 10416754
[TBL] [Abstract][Full Text] [Related]
5. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
Rokicki W; Dorecka M; Romaniuk W
Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
[TBL] [Abstract][Full Text] [Related]
6. Purinergic dysregulation causes hypertensive glaucoma-like optic neuropathy.
Shinozaki Y; Kashiwagi K; Namekata K; Takeda A; Ohno N; Robaye B; Harada T; Iwata T; Koizumi S
JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978804
[TBL] [Abstract][Full Text] [Related]
7. Saving the nerve from glaucoma: memantine to caspaces.
Naskar R; Vorwerk CK; Dreyer EB
Semin Ophthalmol; 1999 Sep; 14(3):152-8. PubMed ID: 10790579
[TBL] [Abstract][Full Text] [Related]
8. [The dawn of neuroprotective therapy for glaucomatous optic neuropathy].
Yamamoto T
Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):866-83. PubMed ID: 11802458
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection: is it already applicable to glaucoma therapy?
Ritch R
Curr Opin Ophthalmol; 2000 Apr; 11(2):78-84. PubMed ID: 10848224
[TBL] [Abstract][Full Text] [Related]
10. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma.
Dreyer EB; Zurakowski D; Schumer RA; Podos SM; Lipton SA
Arch Ophthalmol; 1996 Mar; 114(3):299-305. PubMed ID: 8600890
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma.
Neufeld AH; Sawada A; Becker B
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9944-8. PubMed ID: 10449799
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma.
Neufeld AH
Brain Res Bull; 2004 Feb; 62(6):455-9. PubMed ID: 15036557
[TBL] [Abstract][Full Text] [Related]
13. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part II].
Rokicki W; Dorecka M; Romaniuk W
Klin Oczna; 2007; 109(7-9):353-5. PubMed ID: 18260297
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective therapies for glaucoma.
Song W; Huang P; Zhang C
Drug Des Devel Ther; 2015; 9():1469-79. PubMed ID: 25792807
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection in glaucoma: a model for neuroprotection in optic neuropathies.
Marcic TS; Belyea DA; Katz B
Curr Opin Ophthalmol; 2003 Dec; 14(6):353-6. PubMed ID: 14615639
[TBL] [Abstract][Full Text] [Related]
16. Should we treat the brain in glaucoma?
Gupta N; Yücel YH
Can J Ophthalmol; 2007 Jun; 42(3):409-13. PubMed ID: 17508036
[TBL] [Abstract][Full Text] [Related]
17. Is neuroprotection a viable therapy for glaucoma?
Weinreb RN; Levin LA
Arch Ophthalmol; 1999 Nov; 117(11):1540-4. PubMed ID: 10565524
[TBL] [Abstract][Full Text] [Related]
18. Excitatory mechanisms in retinal ganglion cell death in primary open angle glaucoma (POAG).
Dreyer EB; Grosskreutz CL
Clin Neurosci; 1997; 4(5):270-3. PubMed ID: 9292254
[TBL] [Abstract][Full Text] [Related]
19. A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma.
Neufeld AH; Das S; Vora S; Gachie E; Kawai S; Manning PT; Connor JR
J Glaucoma; 2002 Jun; 11(3):221-5. PubMed ID: 12140399
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat.
Nucci C; Tartaglione R; Rombolà L; Morrone LA; Fazzi E; Bagetta G
Neurotoxicology; 2005 Oct; 26(5):935-41. PubMed ID: 16126273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
